Drug Pipeline

Marstacimab Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
5
Active Studies
4
Recruiting
2
Phase 3
2
Top Sponsors
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-06-04 NCT06703606
A Study to Learn About How Changing Therapy From Emicizumab to Marstacimab Affects People…
Trial sites expanded: 4 -> 7 locations
Active Studies by Phase
Phase 3
2
Phase 1
1
Not specified
2
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT05145127 Open-Label Extension Study of Marstacimab in Hemophilia Participants With or Without… Hemophilia A Recruiting
NCT05611801 A Clinical Trial of Study Medicine (Marstacimab) in Pediatric Patients With Hemophilia A… Hemophilia A Recruiting
Phase 1
NCT06703606 A Study to Learn About How Changing Therapy From Emicizumab to Marstacimab Affects People… Severe Hemophilia A Recruiting
Not specified
NCT06992076 Adult and Adolescent Hemophilia Patients Treated With Marstacimab: a Patient Experience… Hemophilia Recruiting
NCT07161687 A Study to Learn About the Study Medicine -Hympavzi in Congenital Hemophilia Patients… Hemophilia A or B Active, Not Recruiting
Sponsors Running Marstacimab Trials
Disease Areas
Get alerts when Marstacimab trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free